CA3176584A1 - Silver salt-containing ophthalmic aqueous composition filled in resin container - Google Patents
Silver salt-containing ophthalmic aqueous composition filled in resin containerInfo
- Publication number
- CA3176584A1 CA3176584A1 CA3176584A CA3176584A CA3176584A1 CA 3176584 A1 CA3176584 A1 CA 3176584A1 CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A1 CA3176584 A1 CA 3176584A1
- Authority
- CA
- Canada
- Prior art keywords
- aqueous composition
- ophthalmic aqueous
- ophthalmic
- present
- based resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Bridges Or Land Bridges (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020062252 | 2020-03-31 | ||
| JP2020-062252 | 2020-03-31 | ||
| PCT/JP2021/007366 WO2021199814A1 (ja) | 2020-03-31 | 2021-02-26 | 樹脂製容器に充填された銀塩含有眼科用水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3176584A1 true CA3176584A1 (en) | 2021-10-07 |
Family
ID=77930318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3176584A Pending CA3176584A1 (en) | 2020-03-31 | 2021-02-26 | Silver salt-containing ophthalmic aqueous composition filled in resin container |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230145529A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4129341A4 (cg-RX-API-DMAC10.html) |
| JP (4) | JP7053966B2 (cg-RX-API-DMAC10.html) |
| KR (2) | KR20240135080A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115348871B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3176584A1 (cg-RX-API-DMAC10.html) |
| TW (2) | TW202604499A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021199814A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022044701A (ja) * | 2022-01-24 | 2022-03-17 | 参天製薬株式会社 | インジェクションブロー成形されたマルチドーズ型点眼容器に収容される水性懸濁液 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| JP4683835B2 (ja) * | 2003-12-01 | 2011-05-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| KR100557679B1 (ko) * | 2004-01-07 | 2006-03-07 | 뉴바이오 (주) | 4차암모늄의 공중합에 의한 콘택트렌즈제조방법 |
| JP4856392B2 (ja) | 2004-04-23 | 2012-01-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| JP2006162648A (ja) | 2004-12-02 | 2006-06-22 | Konica Minolta Business Technologies Inc | 現像装置及び画像形成装置 |
| MX2010004211A (es) * | 2007-10-16 | 2010-06-30 | Sun Pharma Advanced Res Co Ltd | Composicion oftalmica que comprende una prostaglandina. |
| TW201340960A (zh) * | 2012-02-27 | 2013-10-16 | Rohto Pharma | 眼科用組成物套組 |
| US20150366879A1 (en) * | 2013-02-15 | 2015-12-24 | Senju Pharmaceutical Co., Ltd. | Difluprednate emulsion composition containing antimicrobial metal |
| TWI623313B (zh) * | 2013-03-13 | 2018-05-11 | Santen Pharmaceutical Co Ltd | 瞼板腺功能障礙之治療劑 |
| EA034517B1 (ru) * | 2014-12-25 | 2020-02-17 | Сантен Фармасьютикал Ко., Лтд. | Водный офтальмологический раствор |
| JP6611444B2 (ja) * | 2015-03-24 | 2019-11-27 | ロート製薬株式会社 | 眼科用組成物 |
| TWI743858B (zh) | 2015-06-05 | 2021-10-21 | 日商參天製藥股份有限公司 | 使水性點眼液中之洛赫西定類安定化之方法 |
| JP6615548B2 (ja) * | 2015-08-06 | 2019-12-04 | ロート製薬株式会社 | 眼科組成物 |
| WO2019107569A1 (ja) * | 2017-12-01 | 2019-06-06 | 参天製薬株式会社 | 眼科用製品 |
| CN116018882A (zh) * | 2018-06-28 | 2023-04-25 | Csp高级解决方案株式会社 | 流行性角膜结膜炎的治疗用滴眼剂、生成该滴眼剂的等离子体活性滴眼剂生成装置及流行性角膜结膜炎的治疗方法 |
| JP7139206B2 (ja) | 2018-09-21 | 2022-09-20 | 小林製薬株式会社 | 医薬組成物 |
-
2021
- 2021-02-26 EP EP21781950.7A patent/EP4129341A4/en active Pending
- 2021-02-26 CN CN202180026304.3A patent/CN115348871B/zh active Active
- 2021-02-26 JP JP2021552932A patent/JP7053966B2/ja active Active
- 2021-02-26 US US17/914,976 patent/US20230145529A1/en not_active Abandoned
- 2021-02-26 TW TW114132350A patent/TW202604499A/zh unknown
- 2021-02-26 KR KR1020247029902A patent/KR20240135080A/ko active Pending
- 2021-02-26 CA CA3176584A patent/CA3176584A1/en active Pending
- 2021-02-26 KR KR1020227037013A patent/KR102705675B1/ko active Active
- 2021-02-26 WO PCT/JP2021/007366 patent/WO2021199814A1/ja not_active Ceased
- 2021-02-26 TW TW110107071A patent/TWI896607B/zh active
-
2022
- 2022-03-31 JP JP2022058115A patent/JP7169477B2/ja active Active
- 2022-10-26 JP JP2022171413A patent/JP7721498B2/ja active Active
-
2025
- 2025-07-29 JP JP2025126160A patent/JP2025146955A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023001184A (ja) | 2023-01-04 |
| TWI896607B (zh) | 2025-09-11 |
| JP2025146955A (ja) | 2025-10-03 |
| KR20240135080A (ko) | 2024-09-10 |
| CN115348871A (zh) | 2022-11-15 |
| JPWO2021199814A1 (cg-RX-API-DMAC10.html) | 2021-10-07 |
| JP7721498B2 (ja) | 2025-08-12 |
| US20230145529A1 (en) | 2023-05-11 |
| TW202203920A (zh) | 2022-02-01 |
| EP4129341A1 (en) | 2023-02-08 |
| CN115348871B (zh) | 2025-08-08 |
| EP4129341A4 (en) | 2024-04-24 |
| KR20220161379A (ko) | 2022-12-06 |
| JP2022087168A (ja) | 2022-06-09 |
| TW202604499A (zh) | 2026-02-01 |
| KR102705675B1 (ko) | 2024-09-11 |
| WO2021199814A1 (ja) | 2021-10-07 |
| JP7053966B2 (ja) | 2022-04-12 |
| JP7169477B2 (ja) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6903448B2 (ja) | ドルゾラミドとブリモニジンを含む医薬組成物 | |
| JP2023093601A (ja) | 眼科用製品 | |
| JP2025146955A (ja) | 樹脂製容器に充填された銀塩含有眼科用水性組成物 | |
| KR102075173B1 (ko) | 보존 효력을 갖는 브롬페낙 수성 액제 조성물 | |
| US11324829B2 (en) | Antiseptic agent comprising meglumine or salt thereof | |
| JP2022180452A (ja) | レバミピドまたはその塩および高分子を含有する水性懸濁液 | |
| JP6702754B2 (ja) | ドルゾラミドを含有する防腐剤 | |
| JP6877613B2 (ja) | 防腐効果のある医薬の組合せ | |
| JP4892291B2 (ja) | 眼科用防腐組成物 | |
| JP2023155169A (ja) | 眼科用水性組成物 | |
| WO2023204297A1 (ja) | セペタプロストを含有する眼科用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250121 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250121 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250121 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250219 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250303 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250430 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250508 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260128 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260128 |